Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 4995 | 1.36 |
09:34 ET | 12692 | 1.335 |
09:36 ET | 1404 | 1.34 |
09:38 ET | 1000 | 1.345 |
09:39 ET | 13218 | 1.35 |
09:41 ET | 1500 | 1.355 |
09:43 ET | 4399 | 1.37 |
09:45 ET | 6979 | 1.38 |
09:48 ET | 6231 | 1.365 |
09:50 ET | 3630 | 1.37 |
09:52 ET | 2640 | 1.375 |
09:54 ET | 3800 | 1.3709 |
09:56 ET | 2700 | 1.375 |
09:57 ET | 2481 | 1.3779 |
09:59 ET | 2260 | 1.375 |
10:01 ET | 2988 | 1.375 |
10:03 ET | 18546 | 1.365 |
10:06 ET | 1526 | 1.375 |
10:08 ET | 6808 | 1.365 |
10:10 ET | 700 | 1.365 |
10:12 ET | 1200 | 1.365 |
10:14 ET | 10550 | 1.365 |
10:17 ET | 1928 | 1.36 |
10:21 ET | 423 | 1.36 |
10:24 ET | 400 | 1.355 |
10:26 ET | 1633 | 1.355 |
10:28 ET | 600 | 1.355 |
10:30 ET | 720 | 1.35 |
10:32 ET | 900 | 1.35 |
10:33 ET | 6456 | 1.345 |
10:35 ET | 900 | 1.34 |
10:37 ET | 600 | 1.34 |
10:39 ET | 500 | 1.34 |
10:42 ET | 400 | 1.34 |
10:44 ET | 600 | 1.345 |
10:46 ET | 200 | 1.345 |
10:48 ET | 700 | 1.345 |
10:50 ET | 400 | 1.34 |
10:51 ET | 900 | 1.345 |
10:53 ET | 32858 | 1.345 |
10:55 ET | 1157 | 1.345 |
10:57 ET | 4405 | 1.345 |
11:00 ET | 4583 | 1.335 |
11:02 ET | 20755 | 1.3375 |
11:04 ET | 7838 | 1.335 |
11:06 ET | 3125 | 1.33 |
11:08 ET | 11854 | 1.33 |
11:09 ET | 2908 | 1.325 |
11:11 ET | 18843 | 1.32 |
11:13 ET | 6471 | 1.32 |
11:15 ET | 2427 | 1.33 |
11:18 ET | 800 | 1.325 |
11:20 ET | 5660 | 1.335 |
11:24 ET | 1000 | 1.3388 |
11:26 ET | 100 | 1.34 |
11:27 ET | 120 | 1.34 |
11:31 ET | 620 | 1.335 |
11:33 ET | 3776 | 1.335 |
11:36 ET | 12667 | 1.325 |
11:38 ET | 4898 | 1.325 |
11:40 ET | 3983 | 1.32 |
11:42 ET | 9954 | 1.32 |
11:44 ET | 2585 | 1.3275 |
11:45 ET | 5617 | 1.3177 |
11:47 ET | 8109 | 1.32 |
11:49 ET | 12619 | 1.315 |
11:51 ET | 23890 | 1.305 |
11:54 ET | 12359 | 1.31 |
11:56 ET | 9407 | 1.305 |
11:58 ET | 2277 | 1.305 |
12:00 ET | 1446 | 1.315 |
12:02 ET | 2581 | 1.31 |
12:03 ET | 4523 | 1.3159 |
12:05 ET | 6016 | 1.31 |
12:07 ET | 12714 | 1.305 |
12:09 ET | 9792 | 1.3 |
12:12 ET | 7431 | 1.2905 |
12:14 ET | 2740 | 1.29 |
12:16 ET | 8517 | 1.29 |
12:18 ET | 8507 | 1.295 |
12:20 ET | 4137 | 1.29 |
12:21 ET | 13202 | 1.29 |
12:23 ET | 5648 | 1.29 |
12:25 ET | 7288 | 1.29 |
12:27 ET | 7783 | 1.29 |
12:30 ET | 7609 | 1.285 |
12:32 ET | 7986 | 1.289 |
12:34 ET | 6970 | 1.29 |
12:36 ET | 8734 | 1.285 |
12:38 ET | 14159 | 1.28 |
12:39 ET | 14947 | 1.285 |
12:41 ET | 7300 | 1.285 |
12:43 ET | 5303 | 1.2867 |
12:45 ET | 18600 | 1.2801 |
12:48 ET | 7411 | 1.295 |
12:52 ET | 1100 | 1.295 |
12:54 ET | 1100 | 1.295 |
12:56 ET | 1300 | 1.3 |
12:57 ET | 5627 | 1.3 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 105.2M | 6.6x | --- |
Spero Therapeutics Inc | 73.2M | 3.3x | --- |
2Seventy Bio Inc | 202.5M | -0.9x | --- |
Rigel Pharmaceuticals Inc | 142.9M | -7.2x | --- |
G1 Therapeutics Inc | 139.1M | -4.3x | --- |
Fortress Biotech Inc | 38.6M | -0.3x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $105.2M |
---|---|
Revenue (TTM) | $119.2M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.07 |
EPS | $0.20 |
Book Value | $-0.70 |
P/E Ratio | 6.6x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 5.7x |
Operating Margin | 9.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.